Sort
40,608 grants matching “prostate cancer”
PHASE I STUDIES OF ANTICANCER AGENTS
$449,651Sloan-Kettering Institute For Cancer Res · U01 · FY2002 · CA
Kidney DNA Adductomics
$449,646Robert J. Turesky · University Of Minnesota · R01 · FY2020 · ES
Molecular Imaging with FACBC PET-CT to Improve Post prostatectomy Radiotherapy
$449,629Ashesh Jani · Emory University · R01 · FY2014 · CA
Role of STEAP2 protein in hepatocarcinogenesis
$449,583Luzhe Sun · University Of Texas Hlth Science Center · R01 · FY2020 · CA
Functional Analysis of Cancer Genes from Human Chromosome 3p
$449,562Michael Lerman · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
PROGRAM LEADERSHIP
$449,436William George Nelson · Johns Hopkins University · P30 · FY2016 · CA
CNS sirtuins in radiation-induced vascular permeability and neurodegeneration
$449,399Deedee Smart · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Agents for Specific NMR and SQUID Imaging of Prostate Cancer
$449,390Laurel O Sillerud · University Of New Mexico · R01 · FY2011 · CA
Association of inflammatory genes and prostate cancer
$449,348Jianfeng Xu · Wake Forest University Health Sciences · R01 · FY2006 · CA
Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE
$449,314Aasthaa Bansal · University Of Washington · R37 · FY2020 · CA
Clinical and pre-clinical investigation of extracellular vesicles as a mechanism of toxicity in the bladder of prostate cancer patients treated with radiotherapy
$449,295Yi-Fen Lee · University Of Rochester · R01 · FY2024 · CA
The origins of metabolic reprogramming in prostate cancer
$449,272Andrew S Goldstein · University Of California Los Angeles · R01 · FY2020 · CA
The origins of metabolic reprogramming in prostate cancer
$449,272Andrew S Goldstein · University Of California Los Angeles · R01 · FY2021 · CA
Administrative Core
$449,269Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · G12 · FY2017 · MD
Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE
$449,121Aasthaa Bansal · University Of Washington · R37 · FY2019 · CA
Real time fine needle assessment of architectural heterogeneity in prostate cancer
$449,106Guan Xu · University Of Michigan At Ann Arbor · R37 · FY2024 · CA
Targeting SEMA3C in Castration Resistant Prostate Cancer
$449,099Martin Gleave · Fred Hutchinson Cancer Research Center · P50 · FY2016 · CA
QUANTITATIVE DUAL-ENERGY CT IMAGING FOR CANCER IMAGING AND RADIATION THERAPY APPLICATIONS
$449,002Joseph A O'Sullivan · Washington University · R01 · FY2019 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$448,659James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
The development of Saccharomyces (yeast) vaccines for cancer therapy
$448,659James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Implementation of evidence-based cancer early detection in Black churches
$448,656Cheryl L Holt · Univ Of Maryland, College Park · R01 · FY2015 · CA
A Serum Marker for Aggressive Prostate Cancer
$448,648Donna M Peehl · Stanford University · R01 · FY2010 · CA
Colorectal cancer risk factors, risk prediction and blood-based biomarker by tumor consensus molecular subtype
$448,631Jennifer Sarah Davis · University Of Tx Md Anderson Can Ctr · U01 · FY2019 · CA
Molecular Genetic Dissection of Photoreceptor Function
$448,552Purdue University West Lafayette · R01 · FY2005 · EY
Targeting AR and AR-Variants in Castration-Resistant Prostate Cancer
$448,534Chendil Damodaran · Texas A&M University Health Science Ctr · R01 · FY2022 · CA